Drug recall · August 14, 2013
Latanoprost Ophthalmic Solution recall
Why: Lack of Assurance of Sterility: Failed at expiry for Preservative Effectiveness Test (PET), therefore the product may be susceptible to microbial growth before the expiry date.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Latanoprost Ophthalmic Solution, 0.005% (125 mcg/2.5 mL), 2.5 mL bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario Canada M9L 1T9; Manufactured for: Apotex Corp., Weston, FL 33326; NDC 60505-0565-1; UPC 3 60505 05651 4.
- Lots / codes
Lot #: JX1877, Exp 06/13
- Quantity
- 50,982 bottles
- Company
- Apotex Inc, Richmond Hill, N/A
- Distribution
- Nationwide
- Initiated
- June 25, 2013 · Voluntary: Firm initiated
- Classified
- August 8, 2013
- Reported
- August 14, 2013
- Ended
- April 18, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Latanoprost
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.